Pages that link to "Q28145191"
Jump to navigation
Jump to search
The following pages link to The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group (Q28145191):
Displaying 18 items.
- Interventions for improving adherence to ocular hypotensive therapy (Q24197680) (← links)
- Interventions for improving adherence to ocular hypotensive therapy (Q24241641) (← links)
- Effects of brinzolamide on ocular haemodynamics in healthy volunteers (Q24671182) (← links)
- A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients (Q34218659) (← links)
- Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension (Q35562610) (← links)
- Short-term effect of topical brinzolamide-timolol fixed combination on ocular surface of glaucoma patients (Q36490454) (← links)
- Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation (Q37126415) (← links)
- Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension (Q37444622) (← links)
- Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension (Q37577462) (← links)
- Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension (Q38568639) (← links)
- Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study (Q41279476) (← links)
- Crystal structure of Brinzolamide: a carbonic anhydrase inhibitor (Q41863129) (← links)
- Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension (Q41877762) (← links)
- Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients. (Q42551752) (← links)
- Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countries (Q44296886) (← links)
- Brinzolamide/timolol: in open-angle glaucoma and ocular hypertension. (Q45954943) (← links)
- Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function (Q48245647) (← links)
- Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis (Q91781552) (← links)